Portfolio News
Sofinnova Crossover & Sofinnova Industrial Biotech
Synthace raises £7.3m to accelerate biotechnology to enable faster breakthroughs
Synthace raises £7.3m to accelerate biotechnology to enable faster breakthroughs
Related Company
SynthaceRelated Strategy
CrossoverRelated Strategy
Industrial BiotechRelated Deal lead
Joško BobanovićRelated News
Elevara Medicines appoints biotech veteran as CEO
Sofinnova Partners appoints David Evans as Partner
Tenpoint Therapeutics Announces United Kingdom YUVEZZI™ Submission of Marketing Authorization Application to the Medicines and Healthcare Products Regulatory Agency (MHRA} for the Treatment of Blurry Close-Up Vision (Presbyopia} in Adults
Inventiva Strengthens Board of Directors with Appointment of Three Distinguished Life Sciences Leaders
Abivax Announces Closing of $920 Million Public Offering